Stock GHDN BRAINSTORM CELL THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Brainstorm Cell Therapeutics Inc. Deutsche Boerse AG

Equities

GHDN

US10501E2019

Market Closed - Deutsche Boerse AG
Other stock markets
 07:12:54 27/06/2024 BST 		5-day change 1st Jan Change
0.355 EUR -0.28% Intraday chart for Brainstorm Cell Therapeutics Inc. -5.96% +54.35%
06-27 Brainstorm Cell Therapeutics Prices Registered Direct Offering, Concurrent Private Placement MT
06-26 Brainstorm Cell Therapeutics Inc. Reaches Alignment with Fda on Cmc Aspects of Phase 3B Nurown®? Clinical Trial CI

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

  1. Stock Market
  2. Equities
  3. BCLI Stock
  4. GHDN Stock
  5. Revisions Brainstorm Cell Therapeutics Inc.